BB Biotech AG's Form 4 filing
Molecular Templates, Inc. (MTEM) · filed Nov 18, 2024
- Accession no.
- 0000950170-24-128208
- Filed
- Nov 18, 2024, 9:12 PM ET
- Trade date
- Apr 2-Nov 14, 2024
- Filing delay
- 230 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market sales total $845.8K. It was filed 230 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| BB Biotech AGCIK 0000924223 | 10% Owner |
| Biotech Target N VCIK 0001259870 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2024 | Common Stock | SSaleDisposed | −1,279,820 | $0.6609 | −$845,833.04 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | Common Stock | PPurchaseAcquired | +134,667 | $2.35 | +$316,332.78 | 134,667 | Direct | Duplicate filing |
| Apr 2, 2024 | Common Stock | PPurchaseAcquired | +769,334 | $0.125 | +$96,166.75 | 769,334 | Direct | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.